RARE MDS/MPN OVERLAP: WHEN JAK2 V617F MEETS DEL(5Q) MUTATION

被引：0

作者：

Rupoli, S. ^{[1
]}

Morsia, E. ^{[2
]}

Goteri, G. ^{[2
,3
]}

Capelli, D. ^{[1
]}

Scortechini, A. R. ^{[1
]}

Poloni, A. ^{[1
,2
]}

Micucci, G. ^{[2
]}

Garvey, K. B. ^{[2
]}

Ceglie, S. ^{[2
]}

Fiorentini, A. ^{[2
]}

Angelini, M. ^{[4
]}

Mancini, S. ^{[5
]}

Discepoli, G. ^{[6
]}

Viola, N. ^{[7
]}

Olivieri, A. ^{[1
,2
]}

机构：

[1] Osped Riuniti Ancona, Clin Ematol, Ancona, Italy

[2] Univ Politecn Marche, Ancona, Italy

[3] Osped Riuniti Ancona, Anat Patol, Ancona, Italy

[4] Osped Mazzoni Ascoli Piceno, Lab Biol Mol, Ascoli Piceno, Italy

[5] Osped Riuniti Ancona, Lab Biol Mol, Ancona, Italy

[6] Osped Riuniti Ancona, Lab Citogenet, Ancona, Italy

[7] Osped Riuniti Ancona, Lab Citofluorimetria, Ancona, Italy

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PU40

引用

页码：170 / 170

页数：1

共 50 条

[41] The JAK2 V617F mutation is rare in RARS but common in RARS-T
M M Ceesay
N C Lea
W Ingram
N B Westwood
J Gäken
A Mohamedali
J Cervera
U Germing
N Gattermann
A Giagounidis
Z Garcia-Casado
G Sanz
G J Mufti
Leukemia, 2006, 20 : 2060 - 2061
[42] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
Hamidah, N.
Farisah, N.
Jalil, N.
Fei-Liang, W.
AWahid, F.
Othman, A.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
[43] JAK2 V617F MUTATION SCANNING IN PATIENTS WITH ADRENAL INCIDENTALOMA
Ekinci, F.
Soyaltin, U. E.
Kutbay, Y. B.
Yasar, H. Y.
Yildirim, T. Demirci
Akar, H.
ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 150 - 153
[44] JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia
Johan, MF
Goodeve, AC
Bowen, DT
Frew, ME
Reilly, JT
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (06) : 968 - 968
[45] THE JAK2 V617F MUTATION IN RETINAL VEIN OR ARTERY OCCLUSION
Langabeer, Stephen E.
EXCLI JOURNAL, 2019, 18 : 127 - 128
[46] JAK2 V617F mutation positives in the general population.
Bojesen, S. E.
Nielsen, C.
Birgens, H.
Nordestgaard, B. G.
Kjaer, L.
Hasselbalch, H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[47] KINETICS OF JAK2 V617F MUTATION IN FIVE JAK2 POSITIVE MDS PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
Alchalby, H.
Badbaran, A.
Lioznov, M.
Zander, A. R.
Kroeger, N.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 462 - 462
[48] A case of very rare co-occurrence of POEMS syndrome and JAK2 V617F positive MPN
Alaikov, Tzvetan
Angelova, Svetlana
Hristova, Julieta
Ivanova, Milena
Shivarov, Velizar
JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (01) : 23 - 26
[49] Prognostic relevance of JAK2 V617F mutation in primary myelofibrosis
Barosi, G.
Bergamaschi, G.
Marchetti, M.
Massa, M.
Rosti, V.
Bonetti, E.
Vannucchi, A. M.
Guglielmelli, P.
Antonioli, E.
Campanelli, R.
Villani, L.
Viarengo, G. L.
Barbui, T.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 241 - 241
[50] Absence of JAK2 V617F mutation in thalassemia intermedia patients
Taher, Ali
Shammaa, Dina
Bazarbachi, Ali
Itani, Doha
Zaatari, Ghazi
Greige, Layal
Otrock, Zaher K.
Mahfouz, Rami A. R.
MOLECULAR BIOLOGY REPORTS, 2009, 36 (06) : 1555 - 1557

← 1 2 3 4 5 →